Sunitinib in urothelial cancer: Clinical, pharmacokinetic, and immunohistochemical study of predictors of response Academic Article uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Biomarkers, Tumor
  • Carcinoma, Transitional Cell
  • Immunohistochemistry
  • Indoles
  • Pyrroles
  • Urologic Neoplasms
  • Urothelium
  • Vascular Endothelial Growth Factor Receptor-2

abstract

  • Clinical and molecular biomarkers of response to sunitinib may have clinical relevance and require prospective validation. There is an urgent need for predictive biomarkers to guide the management of UC.

publication date

  • August 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2011.05.034

PubMed ID

  • 21645967

Additional Document Info

start page

  • 344

end page

  • 9

volume

  • 60

number

  • 2